An update on the link between bacteria and autoimmune disease

May 16, 2024 10:21 PM BST | By EIN Presswire
 An update on the link between bacteria and autoimmune disease
Image source: EIN Presswire
CHARLESTOWN, MA, UNITED STATES, May 16, 2024 /EINPresswire.com/ -- From the time of its discovery, people have been intrigued about the unusual form of DNA that is called Z-DNA. Unlike the right-handed Watson-Crick helix everyone hears about at school, Z-DNA is a left-handed helix. There were many questions about why is Z-DNA important in human health and disease, if at all. Intriguingly, the first clue of a biological role came from patients with an autoimmune disease called systemic lupus erythematosus (SLE). In this autoimmune disease where damage to many organs can occur, patients develop antibodies to Z-DNA that tract with disease activity. In an article just published in the Annals of the Rheumatic Diseases, Dr. Pisetsky from Duke University and Alan Herbert from InsideOutBio have just published an update that explains the origins of anti-Z-DNA antibodies and shows the important of unusual DNA conformations in human diseases.

Many roles are now known for Z-DNA in the regulation of gene expression and control of cell death in human cells. These events occur dynamically within cells and involve genomic sequences called flipons that dynamically change conformation. What is unusual about the findings in SLE is that the left-handed Z-DNA is found in outside cells in the external milieux. Even more surprising is that in many cases, the Z-DNA is formed by bacteria as part of the biofilm they use to defend themselves against host responses. The Z-DNA acts as an exoskeleton to protect the bacteria against agents that damage their cell membranes and would otherwise cause them to swell until their membrane ruptures. Biofilms are, for example, one cause of antibiotic resistance. In the context of a bacterial infection, the Z-DNA formed is quite stable. Its persistence can trigger immune responses that lead to the formation of anti-Z_DNA antibodies. Complexes that form between Z-DNA and those antibodies can be trapped in the fine vessels of the skin and kidneys to cause damage to the organs of affected individuals during disease flares. As the disease progresses, the initial immune reaction against Z-DNA can then trigger antibody responses against a range of normal tissues, exacerbating this form of autoimmune disease.

Targeting biofilm formation by bacteria to prevent the Z-DNA formation therefore offers a new opportunity to help patients with SLE.

About InsideOutBio: InsideOutBio is a start-up focused on developing a novel class of proprietary therapeutics to 'light' up tumors for the immune system to kill by reprogramming self/nonself pathways within cancer cells. Dr. Herbert leads discovery at InsideOutBio and contributed to the discovery of flipons. These statements about InsideOutBio comply with Safe-Harbor laws. They are forward-looking and involve known and unknown risks and uncertainties. They are not guarantees of future performance and undue reliance should not be placed on them.

Alan Herbert
InsideOutBio, Inc
+1 617-584-0360
email us here
Visit us on social media:
Twitter
LinkedIn


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalized advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


Sponsored Articles


Investing Ideas

Previous Next